ROS and COVID
In recent years, the pandemic of coronavirus disease 19 (COVID-19), an infectious disease caused by variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has indisputably emerged as the predominant public health issue [...]
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_b886688578c44eefa2b4787ee9c2c1c4 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Periklis Vardakas |e author |
| 700 | 1 | 0 | |a Zoi Skaperda |e author |
| 700 | 1 | 0 | |a Fotios Tekos |e author |
| 700 | 1 | 0 | |a Demetrios Kouretas |e author |
| 245 | 0 | 0 | |a ROS and COVID |
| 260 | |b MDPI AG, |c 2022-02-01T00:00:00Z. | ||
| 500 | |a 10.3390/antiox11020339 | ||
| 500 | |a 2076-3921 | ||
| 520 | |a In recent years, the pandemic of coronavirus disease 19 (COVID-19), an infectious disease caused by variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has indisputably emerged as the predominant public health issue [...] | ||
| 546 | |a EN | ||
| 690 | |a n/a | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Antioxidants, Vol 11, Iss 2, p 339 (2022) | |
| 787 | 0 | |n https://www.mdpi.com/2076-3921/11/2/339 | |
| 787 | 0 | |n https://doaj.org/toc/2076-3921 | |
| 856 | 4 | 1 | |u https://doaj.org/article/b886688578c44eefa2b4787ee9c2c1c4 |z Connect to this object online. |